GeneDx Holdings Corp. Warrant (WGSWW)

• Market cap: $2.03M
• 1 day: -6.33%
• 5 days: 39.22%
• 1 month: -60.56%
• 3 months: -72.69%
• 6 months: -55.60%
• Year to date: -58.82%
• 1 year: 123.27%
• 5 years: -94.93%
• 10 years: -94.93%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Employees: 1,000

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

39% more capital invested

Capital invested by funds: $429K [Q4 2024] → $595K (+$166K) [Q1 2025]

0.35% more ownership

Funds ownership: 9.75% [Q4 2024] → 10.1% (+0.35%) [Q1 2025]

18% less funds holding

Funds holding: 17 [Q4 2024] → 14 (-3) [Q1 2025]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4